Coagulant Market Size 2022 In-Depth Coverage And Various Important Aspects
Coagulants Market Size to Post CAGR of 5.93% Between 2020 and 2027 As per the latest report published by Market Research Future (MRFR), the Middle East & Africa (MEA) coagulants market is set to surge at a strong CAGR of 9.5% during the projected period (2020-2027). In addition, the market is anticipated to reach a valuation of more than 140 Mn towards 2023. Abnormal blood coagulation can have severe health impacts if not attended promptly. The condition literary means change of blood from liquid to gel, which subsequently causes blood clot. Coagulants Market: Competitive Landscape Key players profiled in the global blood coagulants market include Novo Nordisk AS (Dernmark), Bayer AG (Germany), Octapharma (Switzerland), Shire (Republic of Ireland), CSL Limited (Australia), Pfizer Inc. (U.S.), and SOBI (Sweden). Major transformations have taken place in the healthcare sector present in MEA, with GCC countries such UAE, Qatar, Saudi Arabia at the forefront. Significant amount o